To test this hypothesis, we labeled MSX-122 with fluorine-18 and tested whether preincubation with CXCL12 before adding [18F]MSX-122F blocked binding to CXCR4 in the CXCR4-positive metastatic SCCHN cells. Here, CXCR4 is linked to head and neck squamous cell carcinoma.